$RIOT
Riot Platforms, Inc. Stock $riot

$riot Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-K Financial Statement

#000107997313000206 Filed on March 26, 2013

Income Statement

Concept	2013 Q1	2011 Q4	2011 Q3
Revenue		$45.00K	$22.00K
YoY Change		-50.0%	-72.5%
Cost Of Revenue		$0.00	$382.00
YoY Change		-100.0%	-99.75%
Gross Profit		$44.00K	$22.00K
YoY Change		-320.0%	-131.43%
Gross Profit Margin		97.78%	100.0%
Selling, General & Admin	$1.428M	$1.210M	$1.406M
YoY Change	18.53%	-18.24%	-27.15%
% of Gross Profit		2750.0%	6390.81%
Research & Development	$1.412M	$1.290M	$1.645M
YoY Change	108.68%	-24.56%	58.17%
% of Gross Profit		2931.82%	7477.25%
Depreciation & Amortization	$86.81K	$120.0K	$98.00K
YoY Change	-22.72%	-14.29%	-18.33%
% of Gross Profit		272.73%	445.45%
Operating Expenses	$2.840M	$2.490M	$3.051M
YoY Change	50.96%	-21.7%	3.07%
Operating Profit	-$2.821M	-$2.446M	-$3.011M
YoY Change	50.53%	-23.56%	-0.62%
Interest Expense	$44.06K	-$50.00K	-$50.00K
YoY Change		25.0%	150.0%
% of Operating Profit
Other Income/Expense, Net	$19.10K	$0.00	-$52.24K
YoY Change	-129.82%	-100.0%
Pretax Income	-$2.800M	-$1.560M	-$3.060M
YoY Change	44.33%	-47.83%	0.33%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.802M	-$1.557M	-$3.064M
YoY Change	44.58%	-47.93%	0.46%
Net Earnings / Revenue		-3460.0%	-13927.27%
Basic Earnings Per Share
Diluted Earnings Per Share	-$2.258M	-$9.176M	-$18.00M
COMMON SHARES
Basic Shares Outstanding	9.954M
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q1	2011 Q4	2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.300M	$4.000M	$4.800M
YoY Change	389.47%	-66.1%	-66.2%
Cash & Equivalents	$2.492M	$2.968M	$2.401M
Short-Term Investments	$6.800M	$1.000M	$2.400M
Other Short-Term Assets	$300.0K	$300.0K	$500.0K
YoY Change	50.0%	-25.0%	400.0%
Inventory			$0.00
Prepaid Expenses
Receivables		$35.02K	$0.00
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$9.554M	$4.321M	$5.300M
YoY Change	354.97%	-64.87%	-63.45%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.429M	$2.795M	$2.900M
YoY Change	-10.04%	-9.83%	-9.38%
Goodwill	$387.2K	$387.2K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.611M	$1.612M	$0.00
YoY Change
Total Long-Term Assets	$4.040M	$4.407M	$4.700M
YoY Change	-6.05%	-10.07%	-4.08%
TOTAL ASSETS
Total Short-Term Assets	$9.554M	$4.321M	$5.300M
Total Long-Term Assets	$4.040M	$4.407M	$4.700M
Total Assets	$13.59M	$8.728M	$10.00M
YoY Change	112.41%	-49.26%	-48.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$704.8K	$581.7K	$1.500M
YoY Change	40.96%	-47.12%	50.0%
Accrued Expenses	$452.7K	$368.4K	$1.300M
YoY Change	126.37%	-38.6%	116.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.900M	$1.100M	$400.0K
YoY Change	90.0%	266.67%	300.0%
Total Short-Term Liabilities	$3.220M	$2.072M	$3.300M
YoY Change	89.39%	-23.26%	32.0%
LONG-TERM LIABILITIES
Long-Term Debt	$700.0K	$2.800M	$2.500M
YoY Change	-73.08%	12.0%	-3.85%
Other Long-Term Liabilities	$1.300M	$0.00	$600.0K
YoY Change		-100.0%	-14.29%
Total Long-Term Liabilities	$2.000M	$2.800M	$3.100M
YoY Change	-23.08%	-9.68%	-6.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.220M	$2.072M	$3.300M
Total Long-Term Liabilities	$2.000M	$2.800M	$3.100M
Total Liabilities	$5.221M	$4.902M	$6.400M
YoY Change	21.42%	-16.92%	12.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$77.04M	-$65.02M
YoY Change
Common Stock	$85.41M	$68.85M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.373M	$3.826M	$3.600M
YoY Change
Total Liabilities & Shareholders Equity	$13.59M	$8.728M	$10.00M
YoY Change	112.41%	-49.26%	-48.45%

Cashflow Statement

Concept	2013 Q1	2011 Q4	2011 Q3
OPERATING ACTIVITIES
Net Income	-$2.802M	-$1.557M	-$3.064M
YoY Change	44.58%	-47.93%	0.46%
Depreciation, Depletion And Amortization	$86.81K	$120.0K	$98.00K
YoY Change	-22.72%	-14.29%	-18.33%
Cash From Operating Activities	-$2.472M	-$1.920M	-$2.060M
YoY Change	42.5%	-10.28%	-2.83%
INVESTING ACTIVITIES
Capital Expenditures	$10.84K	-$60.00K	-$50.00K
YoY Change		0.0%	0.0%
Acquisitions
YoY Change
Other Investing Activities	-$5.610M	$1.390M	-$1.440M
YoY Change	-1375.0%	-40.34%	3.6%
Cash From Investing Activities	-$5.653M	$1.330M	-$1.490M
YoY Change	-1451.6%	-41.67%	2.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$361.3K	1.150M	-150.0K
YoY Change	7.74%	-866.67%	400.0%
NET CHANGE
Cash From Operating Activities	-$2.472M	-1.920M	-2.060M
Cash From Investing Activities	-$5.653M	1.330M	-1.490M
Cash From Financing Activities	-$361.3K	1.150M	-150.0K
Net Change In Cash	-$8.486M	560.0K	-3.700M
YoY Change	413.8%	-5700.0%	2.78%
FREE CASH FLOW
Cash From Operating Activities	-$2.472M	-$1.920M	-$2.060M
Capital Expenditures	$10.84K	-$60.00K	-$50.00K
Free Cash Flow	-$2.483M	-$1.860M	-$2.010M
YoY Change	43.13%	-10.58%	-2.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	appy	Additional Milestone Maximum Payments AdditionalMilestoneMaximumPayments	2000000	USD
CY2012Q1	appy	Common Stock Market Price High CommonStockMarketPriceHigh	5.88
CY2012Q2	appy	Common Stock Market Price High CommonStockMarketPriceHigh	4.44
CY2012Q3	appy	Common Stock Market Price High CommonStockMarketPriceHigh	2.77
CY2012Q4	appy	Common Stock Market Price High CommonStockMarketPriceHigh	2.93
CY2011Q1	appy	Common Stock Market Price High CommonStockMarketPriceHigh	25.5
CY2011Q2	appy	Common Stock Market Price High CommonStockMarketPriceHigh	23.61
CY2011Q3	appy	Common Stock Market Price High CommonStockMarketPriceHigh	22.5
CY2011Q4	appy	Common Stock Market Price High CommonStockMarketPriceHigh	17.53
CY2012Q1	appy	Common Stock Market Price Low CommonStockMarketPriceLow	3.9
CY2012Q2	appy	Common Stock Market Price Low CommonStockMarketPriceLow	1.88
CY2012Q3	appy	Common Stock Market Price Low CommonStockMarketPriceLow	1.33
CY2012Q4	appy	Common Stock Market Price Low CommonStockMarketPriceLow	2.04
CY2011Q1	appy	Common Stock Market Price Low CommonStockMarketPriceLow	16.8
CY2011Q2	appy	Common Stock Market Price Low CommonStockMarketPriceLow	18.6
CY2011Q3	appy	Common Stock Market Price Low CommonStockMarketPriceLow	14.4
CY2011Q4	appy	Common Stock Market Price Low CommonStockMarketPriceLow	5.82
CY2012	appy	Cumulative Realized Loss On Marketable Securities Maximum CumulativeRealizedLossOnMarketableSecuritiesMaximum	5000	USD
CY2012Q4	appy	Deferred Revenue Net DeferredRevenueNet	1161509	USD
CY2012Q4	appy	License Agreement Maximum Milestone Payments LicenseAgreementMaximumMilestonePayments	1100000	USD
CY2012Q4	appy	License And Milestone Payments Revenue LicenseAndMilestonePaymentsRevenue	1512000	USD
CY2012	appy	License Fees Quarterly LicenseFeesQuarterly	204000	USD
CY2012	appy	Marketable Securities Management Fees MarketableSecuritiesManagementFees	5532	USD
CY2011	appy	Marketable Securities Management Fees MarketableSecuritiesManagementFees	9248	USD
CY2010	appy	Marketable Securities Management Fees MarketableSecuritiesManagementFees	17959	USD
CY2011	appy	Marketable Securities Realized Loss MarketableSecuritiesRealizedLoss	3505	USD
CY2012	appy	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	11192	USD
CY2011	appy	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	1004	USD
CY2010	appy	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	1388	USD
CY2012Q4	appy	Other Other Long Term Assets OtherOtherLongTermAssets	3957	USD
CY2011Q4	appy	Other Other Long Term Assets OtherOtherLongTermAssets	9665	USD
CY2012Q4	appy	Percentage Of Investment Portfolio Cash And Cash Equivalent PercentageOfInvestmentPortfolioCashAndCashEquivalent	0.89
CY2012	appy	Proceeds From Warrants And Stock Options Exercised ProceedsFromWarrantsAndStockOptionsExercised		USD
CY2011	appy	Proceeds From Warrants And Stock Options Exercised ProceedsFromWarrantsAndStockOptionsExercised		USD
CY2010	appy	Proceeds From Warrants And Stock Options Exercised ProceedsFromWarrantsAndStockOptionsExercised	291028	USD
CY2012	dei	Document Type DocumentType	10-K
CY2012	dei	Entity Central Index Key EntityCentralIndexKey	0001167419
CY2013Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9954380
CY2012	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2012	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2012Q2	dei	Entity Public Float EntityPublicFloat	14507000	USD
CY2012	dei	Entity Registrant Name EntityRegistrantName	Venaxis, Inc.
CY2012	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2012	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	613925	USD
CY2012	appy	Stockholders Equity Note Reverse Stock Split Conversion Ratio StockholdersEquityNoteReverseStockSplitConversionRatio	6
CY2011	appy	Weighted Average Number Of Shares Outstanding Pre Reverse Stock Split WeightedAverageNumberOfSharesOutstandingPreReverseStockSplit	8032178
CY2010	appy	Weighted Average Number Of Shares Outstanding Pre Reverse Stock Split WeightedAverageNumberOfSharesOutstandingPreReverseStockSplit	7876081
CY2012	dei	Amendment Flag AmendmentFlag	false
CY2012	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2012	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2012	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012	dei	Document Period End Date DocumentPeriodEndDate	2012-12-31
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	581713	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35016	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	642055	USD
CY2011Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	368406	USD
CY2012Q4	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	-329920	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3078359	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2725981	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1753190	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	181035	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	883471	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	901161	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1336177	USD
CY2010	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2363871	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	-20571	USD
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	-62179	USD
CY2010	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	-68394	USD
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1306000
CY2012	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Reclassifications:</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Certain prior period amounts in the accompanying financial statements have been reclassified to conform to the presentation used in 2012.</div> <!--EndFragment--></div> </div>
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	497000
CY2010	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	214000
CY2012	us-gaap	Asset Impairment Charges AssetImpairmentCharges	44554	USD
CY2011	us-gaap	Asset Impairment Charges AssetImpairmentCharges	274941	USD
CY2010	us-gaap	Asset Impairment Charges AssetImpairmentCharges	107443	USD
CY2012Q4	us-gaap	Assets Assets	16614791	USD
CY2011Q4	us-gaap	Assets Assets	8727845	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	12528358	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	4321044	USD
CY2012Q4	us-gaap	Capital Capital	8449000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10977974	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2968104	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13366777	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8908080	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	8009870	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5939976	USD
CY2010	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4458697	USD
CY2012Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	12141000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2011Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9954380
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1608146
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9954380
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1608146
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	84924133	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	68846796	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	592	USD
CY2011	us-gaap	Cost Of Goods Sold CostOfGoodsSold	16345	USD
CY2010	us-gaap	Cost Of Goods Sold CostOfGoodsSold	358094	USD
CY2012Q4	us-gaap	Deferred Revenue DeferredRevenue	1182080	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	79803	USD
CY2011Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1081706	USD
CY2011Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		USD
CY2012Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	551000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome		USD
CY2012Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	17000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	23000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	26453000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	23505000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		USD
CY2011Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	25100000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	22767000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther		USD
CY2011Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	15000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	32000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	8000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	753000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	692000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	26453000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23505000	USD
CY2012	us-gaap	Depreciation Depreciation	352000	USD
CY2011	us-gaap	Depreciation Depreciation	402000	USD
CY2010	us-gaap	Depreciation Depreciation	395000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	430228	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	490515	USD
CY2010	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	492160	USD
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.84
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-7.61
CY2010	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-10.17
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.2
CY2011Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.96
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2010	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	452878	USD
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	47622	USD
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.19
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.32
CY2012Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.87
CY2011Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.1
CY2011Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.1
CY2011Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.28
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	345692	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	273550	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	75000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	75000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	75000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	75000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	75000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1210698	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1214748	USD
CY2012	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P197M
CY2012	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination		USD
CY2011	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	938896	USD
CY2010	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination		USD
CY2012	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1924	USD
CY2011	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		USD
CY2010	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		USD
CY2012Q4	us-gaap	Goodwill Goodwill	387239	USD
CY2011Q4	us-gaap	Goodwill Goodwill	387239	USD
CY2012	us-gaap	Gross Profit GrossProfit	40965	USD
CY2011	us-gaap	Gross Profit GrossProfit	203075	USD
CY2010	us-gaap	Gross Profit GrossProfit	12135	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	7000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	27000	USD
CY2012Q3	us-gaap	Gross Profit GrossProfit	6000	USD
CY2012Q4	us-gaap	Gross Profit GrossProfit	1000	USD
CY2011Q1	us-gaap	Gross Profit GrossProfit	85000	USD
CY2011Q2	us-gaap	Gross Profit GrossProfit	52000	USD
CY2011Q3	us-gaap	Gross Profit GrossProfit	22000	USD
CY2011Q4	us-gaap	Gross Profit GrossProfit	44000	USD
CY2012	us-gaap	Income Tax Expense Benefit Continuing Operations IncomeTaxExpenseBenefitContinuingOperations		USD
CY2011	us-gaap	Income Tax Expense Benefit Continuing Operations IncomeTaxExpenseBenefitContinuingOperations		USD
CY2010	us-gaap	Income Tax Expense Benefit Continuing Operations IncomeTaxExpenseBenefitContinuingOperations		USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2948000	USD
CY2011	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3275000	USD
CY2010	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4054000	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3132000	USD
CY2011	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3473000	USD
CY2010	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4535000	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	339000	USD
CY2011	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	504000	USD
CY2010	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	881000	USD
CY2012	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	121000	USD
CY2011	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems		USD
CY2010	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems		USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-276000	USD
CY2011	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-306000	USD
CY2010	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-400000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	32212	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	284543	USD
CY2010	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-419377	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-35016	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-38160	USD
CY2010	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25217	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	273649	USD
CY2011	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	210721	USD
CY2010	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-206737	USD
CY2012	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	405256	USD
CY2011	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-179948	USD
CY2010	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-15915	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1182080	USD
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		USD
CY2010	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-407955	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-426825	USD
CY2010	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-403271	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	782165	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9171392	USD
CY2012	us-gaap	Interest Expense InterestExpense	248629	USD
CY2011	us-gaap	Interest Expense InterestExpense	180509	USD
CY2010	us-gaap	Interest Expense InterestExpense	132786	USD
CY2012	us-gaap	Interest Paid InterestPaid	244737	USD
CY2011	us-gaap	Interest Paid InterestPaid	180915	USD
CY2010	us-gaap	Interest Paid InterestPaid	194533	USD
CY2012	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	930937	USD
CY2011	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1336177	USD
CY2010	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2363871	USD
CY2012Q4	us-gaap	Liabilities Liabilities	5923791	USD
CY2011Q4	us-gaap	Liabilities Liabilities	4901967	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16614791	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8727845	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4078953	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2071926	USD
CY2012	us-gaap	License Costs LicenseCosts	408000	USD
CY2012	us-gaap	Licenses Revenue LicensesRevenue	20571	USD
CY2011	us-gaap	Licenses Revenue LicensesRevenue	62179	USD
CY2010	us-gaap	Licenses Revenue LicensesRevenue	68394	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	483000	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2290000	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	75000	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	72000	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	68000	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	65000	USD
CY2012Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	763132	USD
CY2011Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2830041	USD
CY2012	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	102	USD
CY2011	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	1073	USD
CY2010	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	2023	USD
CY2010	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1065	USD
CY2012Q4	us-gaap	Mortgage Loans On Real Estate Periodic Payment Terms Balloon Payment Amount MortgageLoansOnRealEstatePeriodicPaymentTermsBalloonPaymentAmount	1600000	USD
CY2012	us-gaap	Nature Of Operations NatureOfOperations	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Nature of operations:</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Venaxis, Inc. (the "Company" or "Venaxis") was organized on July 24, 2000, as a Colorado corporation. In December 2012, the Company's name was changed to Venaxis, Inc., from AspenBio Pharma, Inc. Venaxis' business is in the development and commercialization of innovative products that address unmet diagnostic and therapeutic needs. The Company's lead product candidate, APPY1, is designed to be a novel blood-based diagnostic test that, if successfully cleared to be marketed by the United States Food and Drug Administration ("FDA"), will aid, through the test's negative predictive value, in the evaluation of low risk patients initially suspected of having acute appendicitis, thereby helping address the difficult challenge of triaging possible acute appendicitis patients in the hospital emergency department or urgent care settings.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The Company's research and development activities are currently focused primarily on a human acute appendicitis blood-based test.</div> <!--EndFragment--></div> </div>
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13814963	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-316118	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1610801	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2923475	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5488975	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8332942	USD
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10706614	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-9212215	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-10213801	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	-13337719	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-1938000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-2310000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-2460000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-2504000	USD
CY2011Q1	us-gaap	Net Income Loss NetIncomeLoss	-2806000	USD
CY2011Q2	us-gaap	Net Income Loss NetIncomeLoss	-2787000	USD
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	-3064000	USD
CY2011Q4	us-gaap	Net Income Loss NetIncomeLoss	-1557000	USD
CY2012	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	480635	USD
CY2011	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	454830	USD
CY2010	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	293873	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-250553	USD
CY2011	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	762387	USD
CY2010	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	111843	USD
CY2012Q4	us-gaap	Notes Payable NotesPayable	3053424	USD
CY2011Q4	us-gaap	Notes Payable NotesPayable	3904226	USD
CY2012Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2290292	USD
CY2011Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1074185	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	9023198	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	11241442	USD
CY2010	us-gaap	Operating Expenses OperatingExpenses	13530091	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-8961662	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-10976188	USD
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	-13449562	USD
CY2012Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	68000000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1601894	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1611652	USD
CY2012	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	112646	USD
CY2011	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	228163	USD
CY2010	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	309898	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43692	USD
CY2011	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2972256	USD
CY2010	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	5206909	USD
CY2010	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	244479	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1924	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000	USD
CY2010	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	244629	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	90100	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	191509	USD
CY2012	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	2991644	USD
CY2011	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1043192	USD
CY2010	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	7628977	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	387480	USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	314800	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15146400	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1456065	USD
CY2010	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9116529	USD
CY2012	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2831864	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5562898	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5521130	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2484539	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2795149	USD
CY2010	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	1310956
CY2012	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1331437	USD
CY2011	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	673900	USD
CY2010	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	236165	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3838375	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5666221	USD
CY2010	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6112405	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74233133	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65020918	USD
CY2012	us-gaap	Royalty Expense RoyaltyExpense	20000	USD
CY2012	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	41557	USD
CY2011	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	219420	USD
CY2010	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	370229	USD
CY2012Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7000	USD
CY2012Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	27000	USD
CY2012Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6000	USD
CY2012Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2000	USD
CY2011Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	97000	USD
CY2011Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	55000	USD
CY2011Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	22000	USD
CY2011Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	45000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5184823	USD
CY2011	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5575221	USD
CY2010	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7417686	USD
CY2012Q4	us-gaap	Short Term Investments ShortTermInvestments	1162904	USD
CY2011Q4	us-gaap	Short Term Investments ShortTermInvestments	1003124	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	10691000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	3825878	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	12813728	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	11247437	USD
CY2011	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	1341379
CY2010	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	291028	USD
CY2012	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	15146400	USD
CY2011	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	1456065	USD
CY2010	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	9116529	USD
CY2012	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	29776	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	901161	USD
CY2011	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1336177	USD
CY2010	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2363871	USD
CY2012	us-gaap	Use Of Estimates UseOfEstimates	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Use of estimates:</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ significantly from those estimates.</div> <!--EndFragment--></div> </div>
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4996827
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1341379
CY2010	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1310956

Files In Submission

Name	View Source	Status
0001079973-13-000206-index-headers.html	Edgar Link	pending
0001079973-13-000206-index.html	Edgar Link	pending
0001079973-13-000206.txt	Edgar Link	pending
0001079973-13-000206-xbrl.zip	Edgar Link	pending
appy-20121231.xml	Edgar Link	completed
appy-20121231.xsd	Edgar Link	pending
appy-20121231_cal.xml	Edgar Link	unprocessable
appy-20121231_def.xml	Edgar Link	unprocessable
appy-20121231_lab.xml	Edgar Link	unprocessable
appy-20121231_pre.xml	Edgar Link	unprocessable
appy_10k-123112.htm	Edgar Link	pending
ex10x12.htm	Edgar Link	pending
ex14.htm	Edgar Link	pending
ex23x1.htm	Edgar Link	pending
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RIOT
Riot Platforms, Inc. Stock $riot

2013 Q1 Form 10-K Financial Statement

#000107997313000206 Filed on March 26, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RIOT Riot Platforms, Inc. Stock $riot

2013 Q1 Form 10-K Financial Statement

#000107997313000206 Filed on March 26, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RIOT
Riot Platforms, Inc. Stock $riot